APA (7th ed.) Citation

O’Callaghan, J., Barry, S. P., Bermingham, M., Morris, J. M., & Griffin, B. T. (2019). Regulation of biosimilar medicines and current perspectives on interchangeability and policy. European journal of clinical pharmacology, 75(1), 1-11. https://doi.org/10.1007/s00228-018-2542-1

Chicago Style (17th ed.) Citation

O’Callaghan, J., S. P. Barry, M. Bermingham, J. M. Morris, and B. T. Griffin. "Regulation of Biosimilar Medicines and Current Perspectives on Interchangeability and Policy." European Journal of Clinical Pharmacology 75, no. 1 (2019): 1-11. https://doi.org/10.1007/s00228-018-2542-1.

MLA (9th ed.) Citation

O’Callaghan, J., et al. "Regulation of Biosimilar Medicines and Current Perspectives on Interchangeability and Policy." European Journal of Clinical Pharmacology, vol. 75, no. 1, 2019, pp. 1-11, https://doi.org/10.1007/s00228-018-2542-1.